Authors:
SCHOTT D
DEMPFLE CE
LIERMAN A
BECK P
KRAMER MD
LIESENHOFF H
NIESSEN KH
MOHRPENNERT A
PHILAPITSCH A
SCHUSTER V
AZUMA H
SCHWARZ HP
Citation: D. Schott et al., HOMOZYGOUS TYPE-I PLASMINOGEN DEFICIENCY - TREATMENT AND PREVENTION OF BLINDNESS BY LONG-TERM REPLACEMENT THERAPY WITH LYS-PLASMINOGEN, Blood, 90(10), 1997, pp. 2666-2666
Authors:
AUER W
MUCHITSCH EM
PHILAPITSCH A
PICHLER L
SCHWARZ HP
Citation: W. Auer et al., STUDIES ON THE EFFECT OF HUMAN LYS-PLASMINOGEN IN A RAT MODEL OF GLOBAL CEREBRAL-ISCHEMIA, Arzneimittel-Forschung, 47(11), 1997, pp. 1195-1199
Authors:
FREITAG HJ
BECKER VU
THIE A
TILSNER V
PHILAPITSCH A
SCHWARZ HP
WEBHOF U
MULLER A
ZEUMER H
Citation: Hj. Freitag et al., LYS-PLASMINOGEN AS AN ADJUNCT TO LOCAL INTRAARTERIAL FIBRINOLYSIS FORCAROTID TERRITORY STROKE - LABORATORY AND CLINICAL FINDINGS, Neuroradiology, 38(2), 1996, pp. 181-185
Citation: A. Philapitsch et Hp. Schwarz, THE EFFECT OF LEUKOCYTE ELASTASE ON PROTEIN-C AND ACTIVATED PROTEIN-C, Thrombosis and haemostasis, 69(6), 1993, pp. 724-724